Los Angeles-based dental technology firm DENTCA has secured FDA 510(k) clearance for its innovative 3D-printable denture base material, marking a milestone in orthodontic care. This groundbreaking light-cured resin is the first of its kind approved for fabricating and repairing full or partial removable dentures and baseplates, ushering in a new era for a century-old manufacturing process.
Rigorously tested for biocompatibility per FDA guidelines and ISO standards, the material ensures safety for long-term tissue contact, passing key assessments for cytotoxicity, sensitization, and irritation. Beyond safety, it delivers transformative efficiency: production speed increases 2.5 times compared to traditional methods, slashing the manufacturing cycle from 30 days to just 5 days.
DENTCA's solution integrates with CAD/CAM systems and Carbon's digital light synthesis technology, enabling dental labs to produce high-precision, color-stable dentures with enhanced durability. Clinical studies show 3D-printed bases offer superior flexural strength and lower water absorption than conventional PMMA materials. Most notably, the technology paves the way for same-day denture printing in clinics, eliminating lengthy patient waits.
"This clearance revolutionizes a process that has barely changed in over 100 years," said DENTCA CEO Sun Kwon. As global demand for dental prosthetics grows amid aging populations, this innovation promises to expand access to customized, cost-effective denture care worldwide.